Search Results - "Anthonisen, N. R"

Mortality in COPD: role of comorbidities by Sin, D. D, Anthonisen, N. R, Soriano, J. B, Agusti, A. G

“…Chronic obstructive pulmonary disease (COPD) represents an increasing burden throughout the world. COPD-related mortality is probably underestimated because of…”
Get full text

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease by Man, S F P, Connett, J E, Anthonisen, N R, Wise, R A, Tashkin, D P, Sin, D D

“…Background: Although C-reactive protein (CRP) levels are increased in chronic obstructive pulmonary disease (COPD), it is not certain whether they are…”
Get full text

Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease by Sin, D D, Wu, L, Anderson, J A, Anthonisen, N R, Buist, A S, Burge, P S, Calverley, P M, Connett, J E, Lindmark, B, Pauwels, R A, Postma, D S, Soriano, J B, Szafranski, W, Vestbo, J

“…Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and improve health status in chronic obstructive pulmonary disease…”
Get full text

Predicting episodes of poor asthma control in treated patients with asthma by McCoy, Karen, Shade, David M., Irvin, Charles G., Mastronarde, John G., Hanania, Nicola A., Castro, Mario, Anthonisen, N.R.

“…Asthma exacerbations are dangerous, expensive, and difficult to anticipate. To characterize patients with asthma who had asthma episodes and exacerbations…”
Get full text

Associations of IL6 polymorphisms with lung function decline and COPD by He, J-Q, Foreman, M G, Shumansky, K, Zhang, X, Akhabir, L, Sin, D D, Man, S F P, DeMeo, D L, Litonjua, A A, Silverman, E K, Connett, J E, Anthonisen, N R, Wise, R A, Paré, P D, Sandford, A J

“…Interleukin-6 (IL6) is a pleiotropic pro-inflammatory and immunomodulatory cytokine which probably plays an important role in the pathogenesis of chronic…”
Get more information

Geographical variations in the prevalence of atopic sensitization in six study sites across Canada by Chan‐Yeung, M., Anthonisen, N. R., Becklake, M. R., Bowie, D., Sonia Buist, A., Dimich‐Ward, H., Ernst, P., Sears, M. R., Siersted, H. C., Sweet, L., Van Til, L., Manfreda, J.

“…To cite this article: Chan‐Yeung M, Anthonisen NR, Becklake MR, Bowie D, Sonia Buist A, Dimich‐Ward H, Ernst P, Sears MR, Siersted HC, Sweet L, Van Til L,…”
Get full text

Bronchodilator response in the lung health study over 11 yrs by Anthonisen, N. R, Lindgren, P. G, Tashkin, D. P, Kanner, R. E, Scanlon, P. D, Connett, J. E, Lung Health Study Research Group

“…Long-term changes in bronchodilator response in people with mild chronic obstructive pulmonary disease were assessed in this study. Changes in forced…”
Get full text

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? by Man, S. F. P, Xing, L, Connett, J. E, Anthonisen, N. R, Wise, R. A, Tashkin, D. P, Zhang, X, Vessey, R, Walker, T. G, Celli, B. R, Sin, D. D

“…The balance between inflammatory and repair processes is important in maintaining lung homeostasis in chronic obstructive pulmonary disease (COPD). The aim of…”
Get full text

Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD by He, J-Q, Shumansky, K, Connett, J. E, Anthonisen, N. R, Pare, P. D, Sandford, A. J

“…Granulocyte-macrophage colony-stimulating factor (CSF), also known as CSF2, and granulocyte CSF, also known as CSF3, are important survival and proliferation…”
Get full text

Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers by Tanaka, G, Sandford, A. J, Burkett, K, Connett, J. E, Anthonisen, N. R, Pare, P. D, He, J-Q

“…Genetic variants in the tumour necrosis factor (TNF) gene have been investigated in chronic obstructive pulmonary disease (COPD). However, there are many…”
Get full text

Association of IL-1β and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers by Joos, L, McIntyre, L, Ruan, J, Connett, J E, Anthonisen, N R, Weir, T D, Paré, P D, Sandford, A J

“…BACKGROUND There is increasing evidence that the cytokine network is central to the immunopathology of inflammatory airway diseases. The interleukin 1 (IL-1)…”
Get full text

Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study by Tan, Wan C, Bourbeau, J, Hernandez, P, Chapman, K, Cowie, R, FitzGerald, M J, Aaron, S, Marciniuk, D D, Maltais, F, O'Donnell, D E, Goldstein, R, Sin, D

“…Currently, no reference or normative values for spirometry based on a randomly selected Canadian population exist. The aim of the present analysis was to…”
Get full text

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease by Anthonisen, N R, Manfreda, J, Warren, C P, Hershfield, E S, Harding, G K, Nelson, N A

“…The effects of broad-spectrum antibiotic and placebo therapy in patients with chronic obstructive pulmonary disease in exacerbation were compared in a…”
Get more information

Polymorphisms of interleukin-10 and its receptor and lung function in COPD by He, J-Q, Shumansky, K, Zhang, X, Connett, J. E, Anthonisen, N. R, Sandford, A. J

“…Interleukin (IL)-10 is a type-2 T-helper cell cytokine with a broad spectrum of anti-inflammatory actions. Inflammation plays an important role in the…”
Get full text

Chronic obstructive pulmonary disease by Anthonisen, N R

Get full text

Use of spirometry and respiratory drugs in Manitobans over 35 years of age with obstructive lung diseases by Anthonisen, N R, Woodlrage, K, Manfreda, J

“…Previous data indicated that spirometry was underused in people with obstructive disease, especially those with chronic obstructive pulmonary disease (COPD)…”
Get full text

Smoking, lung function, and mortality by ANTHONISEN, N R

“…A prompt decline in cardiovascular mortality and morbidity, significant within five years or less after smoking cessation, has been observed before. 7 The best…”
Get full text

Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality by Hill, John, Heslop, Claire, Man, S.F. Paul, Frohlich, Jiri, Connett, John E., Anthonisen, Nick R., Wise, Robert A., Tashkin, Donald P., Sin, Don D.

“…Aims Surfactant protein-D (SP-D) is a lung-specific protein that is detectable in human plasma. We determined the relationship of circulating SP-D to…”
Get full text

Income level and asthma prevalence and care patterns by Erzen, D, Carriere, K C, Dik, N, Mustard, C, Roos, L L, Manfreda, J, Anthonisen, N R

“…Manitoba has a universally accessible health-care system that records physician contacts and hospitalizations in such a way that they can be ascribed to…”
Get more information

Airways obstruction and the risk for lung cancer by Tockman, M S, Anthonisen, N R, Wright, E C, Donithan, M G

“…The presence of airways obstruction identify in middle-aged male smokers at increased risk for lung cancer. This hypothesis was tested in a sample of patients…”
Get more information